Free provider profile

MARK WINDT, M.D.

NPI 1689625600
Individual
Allergy & Immunology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MARK WINDT?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MARK WINDT prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Trelegy Ellipta
  • Fluticasone Propionate
  • Breo Ellipta
  • Dulera
  • Mounjaro

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

603-964-3392

Fax

603-964-3396

Practice address

65 LAFAYETTE RD SECOND FLOOR, NORTH HAMPTON, NH, 03862

Registry updated
2007-07-09
NPI issued
2006-05-15
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

65 LAFAYETTE RD SECOND FLOOR, NORTH HAMPTON, NH, 03862

603-964-3392

Single practice location

Enumerated 2006-05-15

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record last updated 19 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

579

Medicare patients

100

Part D drug cost

$310,757

Brand-name share

51.8%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter)144$138,505
Dupixent Syringe (Dupilumab)13$48,469
Xolair (Omalizumab)11$31,799
Ozempic (Semaglutide)14$22,636
Breo Ellipta (Fluticasone/Vilanterol)41$18,067
Mounjaro (Tirzepatide)17$17,030
Dulera (Mometasone/Formoterol)22$8,470
Fluticasone Propionate (Fluticasone Propionate)63$1,395

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across NH — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.